{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:37:18Z","timestamp":1793497038678,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-03820-5","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T12:18:22Z","timestamp":1676031502000},"page":"1793-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Gestational trophoblastic disease: an update"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1373-4073","authenticated-orcid":false,"given":"Tanya","family":"Chawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-1518","authenticated-orcid":false,"given":"Genevieve","family":"Bouchard-Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-5865","authenticated-orcid":false,"given":"Gulisa","family":"Turashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-8965","authenticated-orcid":false,"given":"Kalesha","family":"Hack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-6714","authenticated-orcid":false,"given":"Phyllis","family":"Glanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"3820_CR1","unstructured":"Jin-Lin Hou 1, Xi-Run Wan, Yang Xiang, Qing-Wei Qi, Xiu-Yu Yang. Changes of clinical features in hydatidiform mole: analysis of 113 cases. J Reprod Med. 2008;53(8):629\u201333."},{"key":"3820_CR2","doi-asserted-by":"crossref","unstructured":"V Soto-Wright 1, M Bernstein, D P Goldstein, R S Berkowitz. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995;86(5):775\u20139.","DOI":"10.1016\/0029-7844(95)00268-V"},{"key":"3820_CR3","doi-asserted-by":"crossref","unstructured":"Sue Yazaki Sun 1, Alexander Melamed 2, Donald P Goldstein 2, Marilyn R Bernstein 2, Neil S Horowitz 2, Antonio Fernandes Moron 1, Izildinha Maest\u00e1 3, Antonio Braga 4, Ross S Berkowitz 5. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol. 2015;138(1):46\u20139.","DOI":"10.1016\/j.ygyno.2015.05.002"},{"issue":"S1","key":"3820_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ijgo.13877","volume":"155","author":"HYS Ngan","year":"2021","unstructured":"Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynecol Obstet. 2021;155(S1):86\u201393.","journal-title":"Int J Gynecol Obstet."},{"issue":"1","key":"3820_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0301-2115(96)02604-8","volume":"71","author":"Y Zalel","year":"1997","unstructured":"Zalel Y, Dgani R. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. Eur J Obstet Gynecol Reprod Biol. 1997;71(1):67\u201371.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"3","key":"3820_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1469-1809.1982.tb00714.x","volume":"46","author":"PA Jacobs","year":"1982","unstructured":"Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS, Wilson CC. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet. 1982;46(3):223\u201331.","journal-title":"Ann Hum Genet."},{"issue":"1","key":"3820_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-pathol-052016-100237","volume":"12","author":"P Hui","year":"2017","unstructured":"Hui P, Buza N, Murphy KM, Ronnett BM. Hydatidiform Moles: Genetic Basis and Precision Diagnosis. Annu Rev Pathol Mech Dis. 2017;12(1):449\u201385.","journal-title":"Annu Rev Pathol Mech Dis."},{"issue":"1","key":"3820_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10024-002-0079-9","volume":"6","author":"NJ Sebire","year":"2003","unstructured":"Sebire NJ, Fisher RA, Rees HC. Histopathological Diagnosis of Partial and Complete Hydatidiform Mole in the First Trimester of Pregnancy. Pediatr Dev Pathol. 2003;6(1):69\u201377.","journal-title":"Pediatr Dev Pathol."},{"issue":"3","key":"3820_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/PGP.0b013e3182626011","volume":"32","author":"N Buza","year":"2013","unstructured":"Buza N, Hui P. Partial Hydatidiform Mole: Histologic Parameters in Correlation with DNA Genotyping. Int J Gynecol Pathol. 2013;32(3):307\u201315.","journal-title":"Int J Gynecol Pathol."},{"issue":"11","key":"3820_CR10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/jclinpath-2014-202517","volume":"67","author":"RA Fisher","year":"2014","unstructured":"Fisher RA, Tommasi A, Short D, Kaur B, Seckl MJ, Sebire NJ. Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit. J Clin Pathol. 2014;67(11):980\u20134.","journal-title":"J Clin Pathol."},{"issue":"4","key":"3820_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000106496","volume":"64","author":"S Sumigama","year":"2007","unstructured":"Sumigama S, Itakura A, Yamamoto T, Nagasaka T, Yamamoto E, Ino K, et al. Genetically Identified Complete Hydatidiform Mole Coexisting with a Live Twin Fetus: Comparison with Conventional Diagnosis. Gynecol Obstet Invest. 2007;64(4):228\u201331.","journal-title":"Gynecol Obstet Invest."},{"issue":"12","key":"3820_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.5858\/arpa.2018-0226-RA","volume":"142","author":"BM Ronnett","year":"2018","unstructured":"Ronnett BM. Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis. Arch Pathol Lab Med. 2018 Dec 1;142(12):1485\u2013502.","journal-title":"Arch Pathol Lab Med."},{"issue":"3","key":"3820_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.semdp.2014.03.004","volume":"31","author":"N Buza","year":"2014","unstructured":"Buza N, Hui P. Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases. Semin Diagn Pathol. 2014;31(3):223\u201332.","journal-title":"Semin Diagn Pathol."},{"issue":"2","key":"3820_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/modpathol.2013.143","volume":"27","author":"N Banet","year":"2014","unstructured":"Banet N, DeScipio C, Murphy KM, Beierl K, Adams E, Vang R, et al. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol. 2014;27(2):238\u201354.","journal-title":"Mod Pathol."},{"issue":"2","key":"3820_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/PGP.0000000000000232","volume":"35","author":"J Bynum","year":"2016","unstructured":"Bynum J, Murphy KM, DeScipio C, Beierl K, Adams E, Anderson D, et al. Invasive Complete Hydatidiform Moles: Analysis of a Case Series with Genotyping. Int J Gynecol Pathol. 2016;35(2):134\u201341.","journal-title":"Int J Gynecol Pathol."},{"issue":"12","key":"3820_CR16","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1053\/hupa.2002.129421","volume":"33","author":"M Fukunaga","year":"2002","unstructured":"Fukunaga M. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol. 2002;33(12):1188\u201392.","journal-title":"Hum Pathol."},{"issue":"4","key":"3820_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.crad.2005.12.003","volume":"61","author":"SD Allen","year":"2006","unstructured":"Allen SD, Lim AK, Seckl MJ, Blunt DM, Mitchell AW. Radiology of gestational trophoblastic neoplasia. Clin Radiol. 2006;61(4):301\u201313.","journal-title":"Clin Radiol."},{"issue":"3 Pt 1","key":"3820_CR18","first-page":"414","volume":"73","author":"C Fine","year":"1989","unstructured":"Fine C, Bundy AL, Berkowitz RS, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol. 1989 Mar;73(3 Pt 1):414\u20138.","journal-title":"Obstet Gynecol."},{"issue":"1","key":"3820_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/uog.3875","volume":"29","author":"E Kirk","year":"2007","unstructured":"Kirk E, Papageorghiou AT, Condous G, Bottomley C, Bourne T. The accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole. Ultrasound Obstet Gynecol. 2007;29(1):70\u20135.","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"1","key":"3820_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/uog.2592","volume":"27","author":"DJ Fowler","year":"2006","unstructured":"Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Routine pre\u2010evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol. 2006;27(1):56\u201360.","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"4","key":"3820_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.radi.2022.06.005","volume":"28","author":"I Newhouse","year":"2022","unstructured":"Newhouse I, Spacey A, Scragg B, Szczepura K. The diagnostic value and accuracy of ultrasound in diagnosing hydatidiform mole: A systematic review and meta-analysis of the literature. Radiography. 2022;28(4):897\u2013905.","journal-title":"Radiography."},{"key":"3820_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.placenta.2017.12.008","volume":"62","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux E, Memtsa M, Johns J, Ross JA, Jurkovic D. New insights in the pathophysiology of complete hydatidiform mole. Placenta. 2018; 62:28\u201333.","journal-title":"Placenta."},{"issue":"4","key":"3820_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/01.ruq.0000191658.95192.89","volume":"21","author":"KA Jain","year":"2005","unstructured":"Jain KA. Gestational trophoblastic disease: pictorial review. Ultrasound Q. 2005;21(4):245\u201353.","journal-title":"Ultrasound Q."},{"issue":"1","key":"3820_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7863\/jum.2005.24.1.15","volume":"24","author":"Q Zhou","year":"2005","unstructured":"Zhou Q, Lei XY, Xie Q, Cardoza JD. Sonographic and Doppler Imaging in the Diagnosis and Treatment of Gestational Trophoblastic Disease: A 12-Year Experience. J Ultrasound Med. 2005;24(1):15\u201324.","journal-title":"J Ultrasound Med."},{"issue":"12","key":"3820_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.6061\/clinics\/2015(12)08","volume":"70","author":"LH Lin","year":"2015","unstructured":"Lin LH, Bernardes LS, Hase EA, Fushida K, Francisco RPV. Is Doppler ultrasound useful for evaluating gestational trophoblastic disease? Clin Sao Paulo Braz. 2015;70(12):810\u20135.","journal-title":"Clin Sao Paulo Braz."},{"issue":"5","key":"3820_CR26","first-page":"1142","volume":"8","author":"R Agarwal","year":"2002","unstructured":"Agarwal R, Strickland S, McNeish IA, Patel DC, Foskett M, Boultbee JE, et al. Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors. Clin Cancer Res Off J Am Assoc Cancer Res. 2002;8(5):1142\u20137.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res."},{"issue":"1","key":"3820_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiology.161.1.3020607","volume":"161","author":"H Hricak","year":"1986","unstructured":"Hricak H, Demas BE, Braga CA, Fisher MR, Winkler ML. Gestational trophoblastic neoplasm of the uterus: MR assessment. Radiology. 1986;161(1):11\u20136.","journal-title":"Radiology."},{"issue":"10","key":"3820_CR28","first-page":"764","volume":"51","author":"BW Hancock","year":"2006","unstructured":"Hancock BW, Nazir K, Everard JE. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med. 2006;51(10):764\u20136.","journal-title":"J Reprod Med."},{"issue":"3","key":"3820_CR29","first-page":"548","volume":"106","author":"AJ Wolfberg","year":"2005","unstructured":"Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E. Postevacuation hCG Levels and Risk of Gestational Trophoblastic Neoplasia in Women with Complete Molar Pregnancy: Obstet Gynecol. 2005;106(3):548\u201352.","journal-title":"Postevacuation hCG Levels and Risk of Gestational Trophoblastic Neoplasia in Women with Complete Molar Pregnancy: Obstet Gynecol."},{"issue":"9223","key":"3820_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(00)02432-6","volume":"356","author":"MJ Seckl","year":"2000","unstructured":"Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, et al. Choriocarcinoma and partial hydatidiform moles. The Lancet. 2000;356(9223):36\u20139.","journal-title":"The Lancet."},{"key":"3820_CR31","doi-asserted-by":"crossref","unstructured":"Eiriksson L, Dean E, Sebastianelli A, Salvador S, Comeau R, Jang JH, et al. Guideline No. 408: Management of Gestational Trophoblastic Diseases. J Obstet Gynaecol Can. 2021;43(1):91\u2013105.e1.","DOI":"10.1016\/j.jogc.2020.03.001"},{"issue":"6","key":"3820_CR32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1471-0528.2007.01320.x","volume":"114","author":"N Sebire","year":"2007","unstructured":"Sebire N, Foskett M, Short D, Savage P, Stewart W, Thomson M, et al. Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit. BJOG Int J Obstet Gynaecol. 2007;114(6):760\u20132.","journal-title":"BJOG Int J Obstet Gynaecol."},{"issue":"1","key":"3820_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ygyno.2013.03.010","volume":"130","author":"C Schmitt","year":"2013","unstructured":"Schmitt C, Doret M, Massardier J, Hajri T, Schott AM, Raudrant D, et al. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type. Gynecol Oncol. 2013;130(1):86\u20139.","journal-title":"Gynecol Oncol."},{"issue":"2","key":"3820_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ygyno.2017.12.008","volume":"148","author":"C Coyle","year":"2018","unstructured":"Coyle C, Short D, Jackson L, Sebire NJ, Kaur B, Harvey R, et al. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients. Gynecol Oncol. 2018;148(2):254\u20137.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"3820_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1471-0528.2003.02388.x","volume":"110","author":"NJ Sebire","year":"2003","unstructured":"Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG Int J Obstet Gynaecol. 2003;110(1):22\u20136.","journal-title":"BJOG Int J Obstet Gynaecol."},{"issue":"2","key":"3820_CR36","first-page":"217","volume":"74","author":"LW Rice","year":"1989","unstructured":"Rice LW, Lage JM, Berkowitz RS, Goldstein DP, Bernstein MR. Repetitive complete and partial hydatidiform mole. Obstet Gynecol. 1989;74(2):217\u20139.","journal-title":"Obstet Gynecol."},{"issue":"5\u20136","key":"3820_CR37","first-page":"188","volume":"59","author":"R Vargas","year":"2014","unstructured":"Vargas R, Barroilhet LM, Esselen K, Diver E, Bernstein M, Goldstein DP, et al. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. J Reprod Med. 2014;59(5\u20136):188\u201394.","journal-title":"J Reprod Med."},{"issue":"2","key":"3820_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ijgc-00009577-200403000-00026","volume":"14","author":"AM Gillespie","year":"2004","unstructured":"Gillespie AM, Lidbury EA, Tidy JA, Hancock BW. The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestation. Int J Gynecol Cancer. 2004;14(2):366\u20139.","journal-title":"Int J Gynecol Cancer."},{"key":"3820_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7618631","volume":"2016","author":"Y Yamada","year":"2016","unstructured":"Yamada Y, Ohira S, Yamazaki T, Shiozawa T. Ectopic Molar Pregnancy: Diagnostic Efficacy of Magnetic Resonance Imaging and Review of the Literature. Case Rep Obstet Gynecol. 2016; 2016:1\u20137.","journal-title":"Case Rep Obstet Gynecol."},{"issue":"9324","key":"3820_CR40","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/S0140-6736(02)09085-2","volume":"359","author":"NJ Sebire","year":"2002","unstructured":"Sebire NJ, Foskett M, Paradinas FJ, Fisher RA, Francis RJ, Short D, et al. Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet Lond Engl. 2002;359(9324):2165\u20136.","journal-title":"Lancet Lond Engl."},{"issue":"4","key":"3820_CR41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000448139","volume":"82","author":"V Giorgione","year":"2017","unstructured":"Giorgione V, Cavoretto P, Cormio G, Valsecchi L, Vimercati A, De Gennaro A, et al. Prenatal Diagnosis of Twin Pregnancies with Complete Hydatidiform Mole and Coexistent Normal Fetus: A Series of 13 Cases. Gynecol Obstet Invest. 2017;82(4):404\u20139.","journal-title":"Gynecol Obstet Invest."},{"issue":"7","key":"3820_CR42","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00261-017-1356-4","volume":"43","author":"TWJ Wu","year":"2018","unstructured":"Wu TWJ, Li YL, Wong KH. The lambda (twin peak) sign. Abdom Radiol. 2018;43(7):1841\u20131841.","journal-title":"Abdom Radiol."},{"key":"3820_CR43","doi-asserted-by":"crossref","unstructured":"McNally L, Rabban JT, Poder L, Chetty S, Ueda S, Chen L may. Differentiating complete hydatidiform mole and coexistent fetus and placental mesenchymal dysplasia: A series of 9 cases and review of the literature. Gynecol Oncol Rep. 2021; 37:100811.","DOI":"10.1016\/j.gore.2021.100811"},{"issue":"6","key":"3820_CR44","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/uog.20290","volume":"53","author":"S Galeva","year":"2019","unstructured":"Galeva S, Gil MM, Konstantinidou L, Akolekar R, Nicolaides KH. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2019;53(6):804\u20139.","journal-title":"Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol."},{"issue":"4","key":"3820_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/ajcp\/aqy039","volume":"150","author":"KY Tse","year":"2018","unstructured":"Tse KY, Chiu KWH, Chan KKL, Chu MMY, Ngu SF, Cheung ANY, et al. A Case Series of Five Patients with Pure or Mixed Gestational Epithelioid Trophoblastic Tumors and a Literature Review on Mixed Tumors. Am J Clin Pathol. 2018;150(4):318\u201332.","journal-title":"Am J Clin Pathol."},{"issue":"2","key":"3820_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0090-8258(90)90048-P","volume":"38","author":"WB Jones","year":"1990","unstructured":"Jones WB, Wagner-Reiss KM, Lewis JL. Intracerebral choriocarcinoma. Gynecol Oncol. 1990;38(2):234\u201343.","journal-title":"Gynecol Oncol."},{"key":"3820_CR47","unstructured":"Bakri YN, Berkowitz RS, Khan J, Goldstein DP, von Sinner W, Jabbar FA. Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure. J Reprod Med. 1994;39(3):175\u20138."},{"issue":"3","key":"3820_CR48","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1006\/gyno.2001.6540","volume":"84","author":"S Yingna","year":"2002","unstructured":"Yingna S, Yang X, Xiuyu Y, Hongzhao S. Clinical Characteristics and Treatment of Gestational Trophoblastic Tumor with Vaginal Metastasis. Gynecol Oncol. 2002;84(3):416\u20139.","journal-title":"Gynecol Oncol."},{"issue":"3","key":"3820_CR49","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ygyno.2019.03.011","volume":"153","author":"A Gadducci","year":"2019","unstructured":"Gadducci A, Carinelli S, Guerrieri ME, Aletti GD. Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy. Gynecol Oncol. 2019;153(3):684\u201393.","journal-title":"Gynecol Oncol."},{"issue":"6","key":"3820_CR50","first-page":"708","volume":"36","author":"O Kuru","year":"2015","unstructured":"Kuru O, Cetin C, Iyibozkurt C, Yavuz E. Placental site trophoblastic tumor: report of a tertiary center experience. Eur J Gynaecol Oncol. 2015;36(6):708\u201310.","journal-title":"Eur J Gynaecol Oncol."},{"issue":"1","key":"3820_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5858\/arpa.2018-0234-RA","volume":"143","author":"P Hui","year":"2019","unstructured":"Hui P. Gestational Trophoblastic Tumors: A Timely Review of Diagnostic Pathology. Arch Pathol Lab Med. 2019;143(1):65\u201374.","journal-title":"Arch Pathol Lab Med."},{"issue":"12","key":"3820_CR52","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1097\/PAS.0000000000000937","volume":"41","author":"J Savage","year":"2017","unstructured":"Savage J, Adams E, Veras E, Murphy KM, Ronnett BM. Choriocarcinoma in Women: Analysis of a Case Series with Genotyping. Am J Surg Pathol. 2017;41(12):1593\u2013606.","journal-title":"Am J Surg Pathol."},{"key":"3820_CR53","doi-asserted-by":"crossref","unstructured":"Kaur B, Short D, Fisher RA, Savage PM, Seckl MJ, Sebire NJ. Atypical Placental Site Nodule (APSN) and Association with Malignant Gestational Trophoblastic Disease; A Clinicopathologic Study of 21 Cases: Int J Gynecol Pathol. 2015;34(2):152\u20138.","DOI":"10.1097\/PGP.0000000000000128"},{"issue":"1","key":"3820_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00004347-200101000-00004","volume":"20","author":"IM Shih","year":"2001","unstructured":"Shih IM, Kurman RJ. The Pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20(1):31\u201347.","journal-title":"Int J Gynecol Pathol."},{"issue":"10","key":"3820_CR55","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/modpathol.3800941","volume":"20","author":"P Hui","year":"2007","unstructured":"Hui P, Wang HL, Chu P, Yang B, Huang J, Baergen RN, et al. Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol. 2007;20(10):1055\u201360.","journal-title":"Mod Pathol."},{"key":"3820_CR56","doi-asserted-by":"crossref","unstructured":"Cirstoiu MM, Sajin M, Baros A, Vasilescu S, Turcan N. The role of the ultrasound examination in atypical placental site trophoblastic tumour differential diagnosis and management. A case reports. Med Ultrason [Internet]. 2021 Jul 1 [cited 2022 Oct 28]; Available from: https:\/\/medultrason.ro\/medultrason\/index.php\/medultrason\/article\/view\/3149","DOI":"10.11152\/mu-3149"},{"issue":"10","key":"3820_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235756","volume":"13","author":"MM Chaves","year":"2020","unstructured":"Chaves MM, Maia T, Cunha TM, Veiga VF. Placental site trophoblastic tumour: the rarest subtype of gestational trophoblastic disease. BMJ Case Rep. 2020;13(10): e235756.","journal-title":"BMJ Case Rep."},{"issue":"2","key":"3820_CR58","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2214\/ajr.170.2.9456970","volume":"170","author":"KR Brandt","year":"1998","unstructured":"Brandt KR, Coakley KJ. MR appearance of placental site trophoblastic tumor: a report of three cases. Am J Roentgenol. 1998;170(2):485\u20137.","journal-title":"Am J Roentgenol."},{"issue":"1","key":"3820_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1067\/j.cpradiol.2011.06.002","volume":"41","author":"KK Kani","year":"2012","unstructured":"Kani KK, Lee JH, Dighe M, Moshiri M, Kolokythas O, Dubinsky T. Gestational trophoblastic disease: multimodality imaging assessment with special emphasis on spectrum of abnormalities and value of imaging in staging and management of disease. Curr Probl Diagn Radiol. 2012;41(1):1\u201310.","journal-title":"Curr Probl Diagn Radiol."},{"issue":"6","key":"3820_CR60","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/uog.12269","volume":"41","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Lu H, Yu C, Tian Q, Lu W. Sonographic characteristics of placental site trophoblastic tumor: Placental site trophoblastic tumor. Ultrasound Obstet Gynecol. 2013 Jun;41(6):679\u201384.","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"11","key":"3820_CR61","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/bjc.2012.462","volume":"107","author":"A Sita-Lumsden","year":"2012","unstructured":"Sita-Lumsden A, Short D, Lindsay I, Sebire NJ, Adjogatse D, Seckl MJ, et al. Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000\u20132009. Br J Cancer. 2012 Nov;107(11):1810\u20134.","journal-title":"Br J Cancer."},{"issue":"1","key":"3820_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2019.07.024","volume":"155","author":"K Balachandran","year":"2019","unstructured":"Balachandran K, Salawu A, Ghorani E, Kaur B, Sebire NJ, Short D, et al. When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients. Gynecol Oncol. 2019 Oct;155(1):8\u201312.","journal-title":"Gynecol Oncol."},{"issue":"3","key":"3820_CR63","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ygyno.2020.06.483","volume":"158","author":"G Bouchard-Fortier","year":"2020","unstructured":"Bouchard-Fortier G, Ghorani E, Short D, Aguiar X, Harvey R, Unsworth N, et al. Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse? Gynecol Oncol. 2020 Sep;158(3):698\u2013701.","journal-title":"Gynecol Oncol."},{"issue":"9 Suppl 3","key":"3820_CR64","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1097\/IGC.0000000000000294","volume":"24","author":"G Mangili","year":"2014","unstructured":"Mangili G, Lorusso D, Brown J, Pfisterer J, Massuger L, Vaughan M, et al. Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2014 Nov;24(9 Suppl 3): S109-116.","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc."},{"issue":"1","key":"3820_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12094-017-1793-0","volume":"20","author":"A Santaballa","year":"2018","unstructured":"Santaballa A, Garc\u00eda Y, Herrero A, La\u00ednez N, Fuentes J, De Juan A, et al. SEOM clinical guidelines in gestational trophoblastic disease (2017). Clin Transl Oncol. 2018 Jan;20(1):38\u201346.","journal-title":"Clin Transl Oncol."},{"key":"3820_CR66","unstructured":"Amin MB, American Joint Committee on Cancer, American Cancer Society, editors. AJCC cancer staging manual. Eight edition \/ editor-in-chief, Mahul B. Amin, MD, FCAP; editors, Stephen B. Edge, MD, FACS [and 16 others]; Donna M. Gress, RHIT, CTR-Technical editor; Laura R. Meyer, CAPM-Managing editor. Chicago IL: American Joint Committee on Cancer, Springer; 2017. 1024 p."},{"key":"3820_CR67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ijgo.12615","volume":"143","author":"HYS Ngan","year":"2018","unstructured":"Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynecol Obstet. 2018 Oct; 143:79\u201385.","journal-title":"Int J Gynecol Obstet."},{"key":"3820_CR68","unstructured":"Organisation mondiale de la sant\u00e9, Centre international de recherche sur le cancer, editors. Female genital tumours. 5th ed. Lyon: International agency for research on cancer; 2020. (World health organization classification of tumours)."},{"issue":"3","key":"3820_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/AOG.0000000000001554","volume":"128","author":"RJ Osborne","year":"2016","unstructured":"Osborne RJ, Filiaci VL, Schink JC, Mannel RS, Behbakht K, Hoffman JS, et al. Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia. Obstet Gynecol. 2016 Sep;128(3):535\u201342.","journal-title":"Obstet Gynecol."},{"issue":"2","key":"3820_CR70","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ygyno.2020.05.013","volume":"158","author":"JC Schink","year":"2020","unstructured":"Schink JC, Filiaci V, Huang HQ, Tidy J, Winter M, Carter J, et al. An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low-risk gestational trophoblastic neoplasia; NRG\/GOG 275. Gynecol Oncol. 2020 Aug;158(2):354\u201360.","journal-title":"Gynecol Oncol."},{"issue":"7","key":"3820_CR71","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1200\/JCO.2010.30.4386","volume":"29","author":"RJ Osborne","year":"2011","unstructured":"Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez Secord A, Kelley JL, et al. Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study. J Clin Oncol. 2011 Mar 1;29(7):825\u201331.","journal-title":"J Clin Oncol."},{"issue":"10110","key":"3820_CR72","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","volume":"390","author":"E Ghorani","year":"2017","unstructured":"Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, et al. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. The Lancet. 2017 Nov;390(10110):2343\u20135.","journal-title":"The Lancet."},{"issue":"6","key":"3820_CR73","first-page":"411","volume":"49","author":"EIO Gamer","year":"2004","unstructured":"Gamer EIO, Garrett A, Goldstein DP, Berkowitz RS. Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. J Reprod Med. 2004 Jun;49(6):411\u20134.","journal-title":"J Reprod Med."},{"key":"3820_CR74","doi-asserted-by":"crossref","unstructured":"Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C, et al. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2013 Oct;24 Suppl 6:vi39\u201350.","DOI":"10.1093\/annonc\/mdt345"},{"issue":"6","key":"3820_CR75","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/s41416-020-01206-8","volume":"124","author":"VL Parker","year":"2021","unstructured":"Parker VL, Winter MC, Whitby E, Parker WAE, Palmer JE, Tidy JA, et al. Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia. Br J Cancer. 2021 Mar 16;124(6):1066\u201371.","journal-title":"Br J Cancer."},{"issue":"1","key":"3820_CR76","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ygyno.2008.10.003","volume":"112","author":"S Darby","year":"2009","unstructured":"Darby S, Jolley I, Pennington S, Hancock BW. Does chest CT matter in the staging of GTN? Gynecol Oncol. 2009 Jan;112(1):155\u201360.","journal-title":"Gynecol Oncol."},{"issue":"5\u20136","key":"3820_CR77","first-page":"199","volume":"59","author":"EL Barber","year":"2014","unstructured":"Barber EL, Schink JC, Lurain JR. Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes. J Reprod Med. 2014 Jun;59(5\u20136):199\u2013203.","journal-title":"J Reprod Med."},{"key":"3820_CR78","doi-asserted-by":"crossref","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, et al. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw JNCCN. 2019 Nov 1;17(11):1374\u201391.","DOI":"10.6004\/jnccn.2019.0100"},{"issue":"1","key":"3820_CR79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ygyno.2015.01.530","volume":"137","author":"P Savage","year":"2015","unstructured":"Savage P, Kelpanides I, Tuthill M, Short D, Seckl MJ. Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome. Gynecol Oncol. 2015 Apr;137(1):73\u20136.","journal-title":"Gynecol Oncol."},{"issue":"6","key":"3820_CR80","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/RLU.0000000000004135","volume":"47","author":"C Bezzi","year":"2022","unstructured":"Bezzi C, Monaco L, Ghezzo S, Mathoux G, Bergamini A, Zambella E, et al. 18F-FDG PET\/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease. Clin Nucl Med. 2022 Jun 1;47(6):525\u201331.","journal-title":"Clin Nucl Med."},{"issue":"6","key":"3820_CR81","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/bjc.2012.65","volume":"106","author":"R Agarwal","year":"2012","unstructured":"Agarwal R, Harding V, Short D, Fisher RA, Sebire NJ, Harvey R, et al. Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia. Br J Cancer. 2012 Mar 13;106(6):1089\u201394.","journal-title":"Br J Cancer."},{"issue":"8","key":"3820_CR82","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/1471-0528.12196","volume":"120","author":"A Sita-Lumsden","year":"2013","unstructured":"Sita-Lumsden A, Medani H, Fisher R, Harvey R, Short D, Sebire N, et al. Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5-6. BJOG Int J Obstet Gynaecol. 2013 Jul;120(8):1012\u20135.","journal-title":"BJOG Int J Obstet Gynaecol."},{"key":"3820_CR83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejrad.2016.12.036","volume":"88","author":"S Sefidbakht","year":"2017","unstructured":"Sefidbakht S, Hosseini F, Bijan B, Hamedi B, Azizi T. Qualitative and quantitative analysis of diffusion-weighted imaging of gestational trophoblastic disease: Can it predict progression of molar pregnancy to persistent form of disease? Eur J Radiol. 2017 Mar; 88:71\u20136.","journal-title":"Eur J Radiol."},{"issue":"1","key":"3820_CR84","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1080\/02656736.2021.1998659","volume":"38","author":"C She","year":"2021","unstructured":"She C, Li S, Wang X, Lu X, Liang H, Liu X. High-intensity focused ultrasound ablation as an adjuvant surgical salvage procedure in gestational trophoblastic neoplasia chemotherapy with chemoresistance or recurrence: two case reports. Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2021;38(1):1584\u20139.","journal-title":"Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-03820-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T11:03:01Z","timestamp":1682852581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-03820-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":84,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["3820"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-03820-5","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}